Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[New drugs and targeted therapeutic agents in ovarian cancer].
de La Motte Rouge T, Petrella MC, Michels J, Even C, Balleyguier C, Duclos J, Mazeron R, Morice P, Pautier P, Lhommé C. de La Motte Rouge T, et al. Among authors: even c. Bull Cancer. 2009 Dec;96(12):1215-24. doi: 10.1684/bdc.2009.0988. Bull Cancer. 2009. PMID: 19919916 Review. French.
[First line chemotherapy of advanced epithelial ovarian cancer].
Lhommé C, Even C, Morice P, Balleyguier C, Petrella M, Gouy S, Uzan C, Duvillard P, Pautier P. Lhommé C, et al. Among authors: even c. Bull Cancer. 2009 Dec;96(12):1207-13. doi: 10.1684/bdc.2009.0987. Bull Cancer. 2009. PMID: 19948450 French.
[Ovarian yolk sac tumour: general review].
Even C, Lhommé C, Duvillard P, Morice P, Balleyguier C, Pautier P, Troalen F, de La Motte Rouge T. Even C, et al. Bull Cancer. 2011 Aug;98(8):963-75. doi: 10.1684/bdc.2011.1387. Bull Cancer. 2011. PMID: 21708513 Review. French.
Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group.
Le Cesne A, Ray-Coquard I, Duffaud F, Chevreau C, Penel N, Bui Nguyen B, Piperno-Neumann S, Delcambre C, Rios M, Chaigneau L, Le Maignan C, Guillemet C, Bertucci F, Bompas E, Linassier C, Olivier T, Kurtz JE, Even C, Cousin P, Yves Blay J; French Sarcoma Group. Le Cesne A, et al. Among authors: even c. Eur J Cancer. 2015 Apr;51(6):742-50. doi: 10.1016/j.ejca.2015.01.006. Epub 2015 Feb 23. Eur J Cancer. 2015. PMID: 25727882
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma.
Ou D, Blanchard P, El Khoury C, De Felice F, Even C, Levy A, Nguyen F, Janot F, Gorphe P, Deutsch E, Temam S, Tao Y. Ou D, et al. Among authors: even c. Oral Oncol. 2016 Nov;62:114-121. doi: 10.1016/j.oraloncology.2016.10.011. Epub 2016 Oct 22. Oral Oncol. 2016. PMID: 27865364
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, Ready NE, Clement PM, Even C, Jang RW, Wong S, Keilholz U, Gilbert J, Fenton M, Braña I, Henry S, Remenar E, Papai Z, Siu LL, Jarkowski A, Armstrong JM, Asubonteng K, Fan J, Melillo G, Mesía R. Zandberg DP, et al. Among authors: even c. Eur J Cancer. 2019 Jan;107:142-152. doi: 10.1016/j.ejca.2018.11.015. Epub 2018 Dec 18. Eur J Cancer. 2019. PMID: 30576970 Free article. Clinical Trial.
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Saleh K, Daste A, Martin N, Pons-Tostivint E, Auperin A, Herrera-Gomez RG, Baste-Rotllan N, Bidault F, Guigay J, Le Tourneau C, Saada-Bouzid E, Even C. Saleh K, et al. Among authors: even c. Eur J Cancer. 2019 Nov;121:123-129. doi: 10.1016/j.ejca.2019.08.026. Epub 2019 Sep 28. Eur J Cancer. 2019. PMID: 31574417
209 results